[
  {
    "ts": null,
    "headline": "Medtronic receives Type 2 label expansion for MiniMed 780G in Europe",
    "summary": "The CE mark also allows Medtronic’s automated insulin delivery system to be used during pregnancy and by children as young as two.",
    "url": "https://finnhub.io/api/news?id=5e8e98a029ab802fdeecf6bf325cb7654e156d5c3fc8e7f705f95e5fd0daa92c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753289959,
      "headline": "Medtronic receives Type 2 label expansion for MiniMed 780G in Europe",
      "id": 136062517,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The CE mark also allows Medtronic’s automated insulin delivery system to be used during pregnancy and by children as young as two.",
      "url": "https://finnhub.io/api/news?id=5e8e98a029ab802fdeecf6bf325cb7654e156d5c3fc8e7f705f95e5fd0daa92c"
    }
  },
  {
    "ts": null,
    "headline": "Insulin Pumps Market Outlook Report 2025, with Leading Player Profiles for Medtronic, Insulet, Tandem Diabetes Care, and More",
    "summary": "The global insulin pump market, valued at USD 4.31 billion in 2024, is projected to soar to USD 7.27 billion by 2030 with a CAGR of 9.10% due to rising diabetes cases and technological advances. In 2024, insulin pumps held over 65% market share, with Type 1 diabetes driving growth at a 9.31% CAGR. North America dominates, capturing over 38% of the market share, while APAC is set for the fastest growth. Key factors include the adoption of automated insulin delivery systems and surging product app",
    "url": "https://finnhub.io/api/news?id=ebd0229af75f25262437a8cf4080700690c9b761b4f65cd5ca4a13ff5abf3a0e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753280880,
      "headline": "Insulin Pumps Market Outlook Report 2025, with Leading Player Profiles for Medtronic, Insulet, Tandem Diabetes Care, and More",
      "id": 136062518,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The global insulin pump market, valued at USD 4.31 billion in 2024, is projected to soar to USD 7.27 billion by 2030 with a CAGR of 9.10% due to rising diabetes cases and technological advances. In 2024, insulin pumps held over 65% market share, with Type 1 diabetes driving growth at a 9.31% CAGR. North America dominates, capturing over 38% of the market share, while APAC is set for the fastest growth. Key factors include the adoption of automated insulin delivery systems and surging product app",
      "url": "https://finnhub.io/api/news?id=ebd0229af75f25262437a8cf4080700690c9b761b4f65cd5ca4a13ff5abf3a0e"
    }
  },
  {
    "ts": null,
    "headline": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever",
    "summary": "Medtronic is closing in on Dividend King status and has a historically high yield.  Becton, Dickinson is already a Dividend King and has a relatively high yield.  Universal Health has a huge yield and a four-decade dividend streak going.",
    "url": "https://finnhub.io/api/news?id=a9e7e2a318665951a9c3905ec1d8b8eabf8aafc5d9e9e2c661349e1303263dc8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753279200,
      "headline": "Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever",
      "id": 136062519,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic is closing in on Dividend King status and has a historically high yield.  Becton, Dickinson is already a Dividend King and has a relatively high yield.  Universal Health has a huge yield and a four-decade dividend streak going.",
      "url": "https://finnhub.io/api/news?id=a9e7e2a318665951a9c3905ec1d8b8eabf8aafc5d9e9e2c661349e1303263dc8"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific lifts annual profit view on steady heart devices demand",
    "summary": "Boston Scientific raised its annual profit forecast on Wednesday, after strong demand for its heart devices helped the U.S. medical device maker beat second-quarter profit estimates. Shares of the Massachusetts-based company rose 2.3% in premarket trading following the results. A rise in surgical procedures has benefited medical device manufacturers such as Boston Scientific, as it boosted sales and helped offset broader concerns about healthcare spending pressures.",
    "url": "https://finnhub.io/api/news?id=bf921fe50832e061b379f70327677b999e0b57c5b094aa8df7459fb211d21e2a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753271919,
      "headline": "Boston Scientific lifts annual profit view on steady heart devices demand",
      "id": 136044322,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Boston Scientific raised its annual profit forecast on Wednesday, after strong demand for its heart devices helped the U.S. medical device maker beat second-quarter profit estimates. Shares of the Massachusetts-based company rose 2.3% in premarket trading following the results. A rise in surgical procedures has benefited medical device manufacturers such as Boston Scientific, as it boosted sales and helped offset broader concerns about healthcare spending pressures.",
      "url": "https://finnhub.io/api/news?id=bf921fe50832e061b379f70327677b999e0b57c5b094aa8df7459fb211d21e2a"
    }
  }
]